View Clinical Trial (Medical Research Study)
A Study to Evaluate the Effects of Milnacipran on Pain Processing and Functional MRI in Patients With Fibromyalgia - NCT01173055-48106(Clinical Trial 713020)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Ann Arbor |
|
State:
|
|
MI |
| Zip Code: |
|
48106 |
| Conditions: |
|
Fibromyalgia |
| Purpose: |
|
Fibromyalgia is a condition that includes pain, tenderness, stiff muscle, and fatigue.
Researchers want to find out if "a drug" called milnacipran can help people with
fibromyalgia. milnacipran (Savella) is approved by the FDA for the management of
fibromyalgia. In this study, milnacipran will be given to find out more about how it affects
pain and thinking in people with fibromyalgia.
|
| Study summary: |
|
The objective of this study is to evaluate the effect of milnacipran on pain processing in
patients with fibromyalgia and to assess the correlation between this effect and neural
activation patterns during fMRI. |
| Criteria: |
|
Inclusion Criteria:
- You may be eligible to take part in this study if the following are true:
- You are between the age of 18 and 70 years
- If you are female
- If you are right handed
- You have a diagnosis of fibromyalgia for at least 3 months, as defined by the
American College of Rheumatology 1990 Criteria
- You are willing to stop taking certain medicines that you may be taking on a
regular basis. The researchers will discuss these medications with you in
detail
Exclusion Criteria:
- You may not be eligible take part in this study if any of the following are true for
you:
- You have problems with your heart or cardiovascular system
- You have problems with your liver or kidneys
- You have an autoimmune disease, or a whole-body infection like HIV or hepatitis
- You have cancer
- You are pregnant or breastfeeding
- You abuse drugs or alcohol
- You have suicidal thoughts or wishes
- You have taken milnacipran or another study drug within the last 30 days
- You have a medical problem not listed here that would make it unsafe for you to
take part in the study
- The research team feels that you will be unable to complete all phases of the
study |
|
|
|
| Study is available at: |
|
University of Michigan, Chronic Pain and Fatigue Research Center
Ann Arbor, MI 48106
United States
Primary Contact:
Kathy Scott, RN,BSN
Email: jrsj@umich.edu
Phone: 734-998-7022
Secondary Contact:
Kathy Scott, RN, BSN
Email: jrsj@umich.edu
Phone: 734-998-7022 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|